Y Intercept (Hong Kong) LTD Novavax Inc Transaction History

Y Intercept (Hong Kong) LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$36.28 - $75.29 $185,572 - $385,108	5,115 New	5,115 $263,000
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $998,702 - $1.52 Million	-5,617 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$121.0 - $257.67 $679,657 - $1.45 Million	5,617 New	5,617 $1.19 Million
Q2 2021 Aug 12, 2021	SELL	$121.0 - $257.67 $261,723 - $557,340	-2,163 Closed	0 $1.19 Million
Q1 2021 May 12, 2021	BUY	$112.98 - $319.93 $8,473 - $23,994	75 Added 3.59%	2,163 $375,000
Q4 2020 Feb 05, 2021	BUY	$78.74 - $139.5 $164,409 - $291,276	2,088 New	2,088 $248,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.